| Product Code: ETC9947674 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Lipid POCT Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Lipid POCT Market - Industry Life Cycle |
3.4 United Kingdom (UK) Lipid POCT Market - Porter's Five Forces |
3.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Platform, 2021 & 2031F |
3.10 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Lipid POCT Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the UK leading to a higher demand for lipid testing |
4.2.2 Technological advancements in lipid POCT devices making testing more efficient and accurate |
4.2.3 Growing focus on preventive healthcare and wellness programs driving the adoption of lipid POCT testing |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for lipid POCT devices limiting market entry |
4.3.2 High cost associated with lipid POCT devices and tests hindering widespread adoption |
4.3.3 Lack of awareness among healthcare professionals and patients about the benefits of lipid POCT testing |
5 United Kingdom (UK) Lipid POCT Market Trends |
6 United Kingdom (UK) Lipid POCT Market, By Types |
6.1 United Kingdom (UK) Lipid POCT Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Kits, 2021- 2031F |
6.2 United Kingdom (UK) Lipid POCT Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Hyperlipidemia, 2021- 2031F |
6.2.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Hypertriglyceridemia, 2021- 2031F |
6.2.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Hyperlipoproteinemia, 2021- 2031F |
6.2.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Familial hypercholesterolemia, 2021- 2031F |
6.2.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Tangier Disease, 2021- 2031F |
6.2.7 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Lipid POCT Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Prescription-Based Testing, 2021- 2031F |
6.3.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By OTC-Based Testing, 2021- 2031F |
6.4 United Kingdom (UK) Lipid POCT Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Roche Reflotron, 2021- 2031F |
6.4.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Roche Cobas B 101, 2021- 2031F |
6.4.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Alere Cholestech LDX, 2021- 2031F |
6.4.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Alere Afinion, 2021- 2031F |
6.4.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Samsung Labgeo, 2021- 2031F |
6.4.7 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By PTS Cardiochek, 2021- 2031F |
6.5 United Kingdom (UK) Lipid POCT Market, By Platform |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Lateral Flow Assays (Immunochromatography Tests), 2021- 2031F |
6.5.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.5.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.5.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Dipsticks, 2021- 2031F |
6.5.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Microfluidics, 2021- 2031F |
6.6 United Kingdom (UK) Lipid POCT Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Professional Diagnostic Centers, 2021- 2031F |
6.6.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Home Care, 2021- 2031F |
6.6.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.6.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Other End Users, 2021- 2031F |
6.7 United Kingdom (UK) Lipid POCT Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.7.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 United Kingdom (UK) Lipid POCT Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Lipid POCT Market Export to Major Countries |
7.2 United Kingdom (UK) Lipid POCT Market Imports from Major Countries |
8 United Kingdom (UK) Lipid POCT Market Key Performance Indicators |
8.1 Average turnaround time for lipid POCT testing |
8.2 Rate of adoption of lipid POCT devices in primary care settings |
8.3 Number of partnerships and collaborations between lipid POCT device manufacturers and healthcare providers |
8.4 Percentage of healthcare professionals trained in using lipid POCT devices |
8.5 Patient satisfaction scores related to lipid POCT testing experience |
9 United Kingdom (UK) Lipid POCT Market - Opportunity Assessment |
9.1 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Platform, 2021 & 2031F |
9.6 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Lipid POCT Market - Competitive Landscape |
10.1 United Kingdom (UK) Lipid POCT Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Lipid POCT Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here